Bellerophon Therapeutics Submits Investigational New Drug Application to Study INOpulse® Inhaled Nitric Oxide Therapy for the Treatment of COVID-19

COVID-19: Redefining Our Present and Future Attitudes Towards Hygiene

Bellerophon Therapeutics Announces First Patient Treated with INOpulse® Inhaled Nitric Oxide Therapy for COVID-19

AgNovos Healthcare Receives Breakthrough Designation for Spine Device

Center for Organ Recovery & Education Receives Katie Coolican-Nicholas Miller Donor Care Award for Excellence in Donor Family Support

FDA Grants Bellerophon Emergency Expanded Access for INOpulse® for the Treatment of COVID-19 Virus

Kuros strengthens orthobiologics patent portfolio

Bellerophon Announces Agreement with the FDA on its Planned Pivotal Phase 3 Study for the Treatment of Pulmonary Hypertension Associated with Pulmonar...

AnGes and Osaka University launch joint DNA vaccine development against Coronavirus Disease 2019 (COVID-19)

Study showing treatment of osteoporotic vertebrae with LOEP enhances biomechanical properties is published in Archives of Orthopaedic and Trauma Surge...